News & Updates

Show Multimedia Only
NT-proBNP predicts cardiorenal complications in Chinese patients with T2D
NT-proBNP predicts cardiorenal complications in Chinese patients with T2D
30 Dec 2024 byChristina Lau

Elevated N-terminal pro–B-type natriuretic peptide (NT-proBNP) levels independently predict cardiorenal complications in Chinese patients with type 2 diabetes (T2D) and can be utilized as a clinical prognostic biomarker for risk stratification to enable more intensive organ-protective treatment in those at risk, a study involving 1,993 patients enrolled in the Hong Kong Diabetes Biobank has shown.

NT-proBNP predicts cardiorenal complications in Chinese patients with T2D
30 Dec 2024
Dark chocolates linked to lower T2D risk
Dark chocolates linked to lower T2D risk
19 Dec 2024
Generic antiobesity drugs viable after successful weight loss with GLP-1 RA
Generic antiobesity drugs viable after successful weight loss with GLP-1 RA
12 Dec 2024 byStephen Padilla

Older-generation generic antiobesity medications (AOMs) for weight maintenance may be prescribed to patients who have achieved successful weight loss with glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, suggests a study.

Generic antiobesity drugs viable after successful weight loss with GLP-1 RA
12 Dec 2024